COX2 Expression in Prognosis and in Prediction to Endocrine Therapy in Early Breast Cancer Patients

Breast Cancer Research and Treatment - Netherlands
doi 10.1007/s10549-010-0854-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Adjuvant Endocrine Therapy in Early Postmenopausal Breast Cancer

Breast Care
SurgeryOncology
2008English

Current Issues With Luminal Subtype Classification in Terms of Prediction of Benefit From Endocrine Therapy in Early Breast Cancer

Histopathology
MedicineForensic MedicinePathologyHistology
2018English

Current Status of Extended Adjuvant Endocrine Therapy in Early Stage Breast Cancer

Current Treatment Options in Oncology
OncologyPharmacology
2018English

How to Overcome Endocrine Resistance in Early and Metastatic Breast Cancer

Chronicles of Oncology
2018English

Recent Advances in Endocrine Therapy of Breast Cancer

BMJ
1997English

Late Recurrences in Early Breast Cancer: For Whom and How Long Is Endocrine Therapy Beneficial?

Breast Care
SurgeryOncology
2014English

Endocrine Therapy of Breast Cancer

2008English

Understanding Adjuvant Endocrine Therapy Persistence in Breast Cancer Survivors

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

ADAMTS1 Promotes Adhesion to Extracellular Matrix Proteins and Predicts Prognosis in Early Stage Breast Cancer Patients

Cellular Physiology and Biochemistry
Physiology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy